Tapewire

Nasdaq · USD

NTRP

NextTrip, Inc.

Export transactions ↓
Tapewire entity
7630
SEC CIK
0000788611
Parsed reports
196

Last 12 months

Inside the activity.

4 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202610
Jun 202610
Jul 202600
Aug 202600
Sep 202610
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 15, 2020 Filed Jun 18, 2020 00:30 UTC
RUPORT MARKDirector · President and CEO
GrantStock Option (right to buy) · Derivative 116,654 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001493152-20-011346 · ownership.xml · derivative · entry 1

RUPORT MARK · CIK 0001030874 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,654

Underlying: Common Stock · 116,654 shares

Expires 2025-05-27

F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on June 15, 2020.

F2 · derivative.exercise_date: The stock option vests as follows: (i) 25% of the shares underlying the option vested on June 15, 2020, and (ii) the balance of the shares underlying the option will vest in equal (as closely as possible) monthly installments over three years from June 15, 2020, subject, in each case, to the Reporting Person being in the continous employ of the Issuer on the applicable vesting date.

Read SEC document
June 15, 2020 Filed Jun 18, 2020 00:30 UTC
Fisher Ronald Kenneth JrVP of Business Development
GrantStock Option (right to buy) · Derivative 23,331 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001493152-20-011345 · ownership.xml · derivative · entry 1

Fisher Ronald Kenneth Jr · CIK 0001698203 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,331

Underlying: Common Stock · 23,331 shares

Expires 2025-05-27

F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on June 15, 2020.

F2 · derivative.exercise_date: The stock option vests as follows: (i) 25% of the shares underlying the option vested on June 15, 2020, and (ii) the balance of the shares underlying the option will vest in equal (as closely as possible) monthly installments over three years from June 15, 2020, subject, in each case, to the Reporting Person being in the continous employ of the Issuer on the applicable vesting date.

Read SEC document
May 01, 2020 Filed May 6, 2020 01:13 UTC GrantStock Option (right to buy) · Derivative 16,044 $0.00 Strike: $2.28 $0.00
Disclosure

SEC source: 0001493152-20-007777 · ownership.xml · derivative · entry 2

Rice John Reynolds · CIK 0001698204 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,044

Underlying: Common Stock · 16,044 shares

Expires 2025-04-30

Read SEC document
May 01, 2020 Filed May 6, 2020 01:13 UTC Disposition to issuerCommon Stock 969 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-007777 · ownership.xml · nonDerivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 523

F1 · shares: The shares shown were forfeited in connection with the Reporting Person's resignation as an employee of the Issuer.

Read SEC document
April 10, 2020 Filed Apr 14, 2020 22:00 UTC
Rice John ReynoldsDirector · President and CEO
GrantCommon Stock 969 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-006418 · ownership.xml · nonDerivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,492

F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date.

Read SEC document
April 10, 2020 Filed Apr 14, 2020 22:00 UTC GrantCommon Stock 1,125 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-006417 · ownership.xml · nonDerivative · entry 1

Beckett Darren · CIK 0001745828 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,125

F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date.

Read SEC document
April 10, 2020 Filed Apr 14, 2020 22:00 UTC
Fisher Ronald Kenneth JrVP of Business Development
GrantCommon Stock 1,125 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-006416 · ownership.xml · nonDerivative · entry 1

Fisher Ronald Kenneth Jr · CIK 0001698203 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,325

F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date.

Read SEC document
April 10, 2020 Filed Apr 14, 2020 22:00 UTC
Orzechowski FrankCFO, PFO and PAO
GrantCommon Stock 969 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-006415 · ownership.xml · nonDerivative · entry 1

Orzechowski Frank · CIK 0001781860 · CFO, PFO and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 969

F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date.

Read SEC document
April 10, 2020 Filed Apr 14, 2020 22:00 UTC
RUPORT MARKDirector · Executive Chairman
GrantCommon Stock 969 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-006414 · ownership.xml · nonDerivative · entry 1

RUPORT MARK · CIK 0001030874 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 969

F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date.

Read SEC document
January 28, 2020 Filed Feb 26, 2020 23:05 UTC GrantWarrants to Purchase Common Stock · Derivative 24,272 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001493152-20-003022 · ownership.xml · derivative · entry 2

Battinelli Salvatore F · CIK 0001714848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,272

Underlying: Common Stock · 24,272 shares

Expires 2025-07-28

F1 · price: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

Read SEC document
January 28, 2020 Filed Feb 26, 2020 23:05 UTC GrantSeries E Preferred Stock · Derivative 16.67 $1,500.00 Strike: $1.03 $25,005.00
Disclosure

SEC source: 0001493152-20-003022 · ownership.xml · derivative · entry 1

Battinelli Salvatore F · CIK 0001714848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16.67

Underlying: Common Stock · 31,756 shares

Expires not disclosed

F1 · security: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

F1 · derivative.expiration_date: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

F2 · derivative.underlying_shares: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1.

Read SEC document
January 28, 2020 Filed Feb 26, 2020 23:05 UTC
RUPORT MARKDirector · Executive Chairman
GrantWarrants to Purchase Common Stock · Derivative 48,544 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001493152-20-003021 · ownership.xml · derivative · entry 2

RUPORT MARK · CIK 0001030874 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,544

Underlying: Common Stock · 48,544 shares

Expires 2025-07-28

F1 · price: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 33.33 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 48,544 shares of the Company's Common Stock for an aggregate purchase price of $50,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

Read SEC document
January 28, 2020 Filed Feb 26, 2020 23:05 UTC
RUPORT MARKDirector · Executive Chairman
GrantSeries E Preferred Stock · Derivative 33.33 $1,500.00 Strike: $1.03 $49,995.00
Disclosure

SEC source: 0001493152-20-003021 · ownership.xml · derivative · entry 1

RUPORT MARK · CIK 0001030874 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33.33

Underlying: Common Stock · 63,494 shares

Expires not disclosed

F1 · security: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 33.33 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 48,544 shares of the Company's Common Stock for an aggregate purchase price of $50,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

F1 · derivative.expiration_date: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 33.33 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 48,544 shares of the Company's Common Stock for an aggregate purchase price of $50,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

F2 · derivative.underlying_shares: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1.

Read SEC document
January 28, 2020 Filed Feb 26, 2020 23:05 UTC
Garofalo Frank JFormer Director
GrantWarrants to Purchase Common Stock · Derivative 24,272 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001493152-20-003020 · ownership.xml · derivative · entry 2

Garofalo Frank J · CIK 0001698160 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,272

Underlying: Common Stock · 24,272 shares

Expires 2025-07-28

F1 · price: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

Read SEC document
January 28, 2020 Filed Feb 26, 2020 23:05 UTC
Garofalo Frank JFormer Director
GrantSeries E Preferred Stock · Derivative 16.67 $1,500.00 Strike: $1.03 $25,005.00
Disclosure

SEC source: 0001493152-20-003020 · ownership.xml · derivative · entry 1

Garofalo Frank J · CIK 0001698160 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16.67

Underlying: Common Stock · 31,756 shares

Expires not disclosed

F1 · security: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

F1 · derivative.expiration_date: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.

F2 · derivative.underlying_shares: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1.

Read SEC document
January 28, 2020 Filed Feb 11, 2021 21:45 UTC
Schwartz Carl I.Former 10% holder
PurchaseWarrants to Purchase Common Stock · Derivative 38,835 Not disclosed Strike: $11.13 Not disclosed
Disclosure

SEC source: 0001179110-21-001589 · edgar.xml · derivative · entry 4

Schwartz Carl I. · CIK 0001573354 · Former 10% holder

10b5-1 filing: Not disclosed

Ownership: Indirect · By Carl & Shirley Schwartz Trust

Disclosed balance after: 38,835

Underlying: Common Stock · 38,835 shares

Expires 2025-07-26

F4 · derivative.exercise_price: Conversion and exercise prices have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020.

F3 · price: Purchase was made in conjunction with purchase of Series E Convertible Preferred Stock.

F1 · derivative.underlying_shares: Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020.

F1 · balance_after: Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020.

Read SEC document
January 28, 2020 Filed Feb 11, 2021 21:45 UTC
Schwartz Carl I.Former 10% holder
PurchaseSeries E Convertible Preferred Stock · Derivative 266.67 $1,500.00 Strike: $10.30 $400,005.00
Disclosure

SEC source: 0001179110-21-001589 · edgar.xml · derivative · entry 3

Schwartz Carl I. · CIK 0001573354 · Former 10% holder

10b5-1 filing: Not disclosed

Ownership: Indirect · By Carl & Shirley Schwartz Trust

Disclosed balance after: 266.67

Underlying: Common Stock · 38,835 shares

Expires not disclosed

F4 · derivative.exercise_price: Conversion and exercise prices have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020.

F2 · derivative.expiration_date: No expiration date.

F1 · derivative.underlying_shares: Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020.

Read SEC document
December 03, 2019 Filed Dec 5, 2019 23:44 UTC
RUPORT MARKDirector · Executive Chairman
GrantStock Option (right to buy) · Derivative 400,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001250853-19-000110 · primary_doc.xml · derivative · entry 2

RUPORT MARK · CIK 0001030874 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2024-12-02

F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal (as closely as possible) monthly installments over three years from the Grant Date, subject to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

Read SEC document
December 03, 2019 Filed Dec 5, 2019 23:44 UTC
RUPORT MARKDirector · Executive Chairman
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001250853-19-000110 · primary_doc.xml · derivative · entry 1

RUPORT MARK · CIK 0001030874 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2024-12-02

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in full on the one month anniversary of December 3, 2019 (the "Grant Date")

Read SEC document
October 11, 2019 Filed Oct 15, 2019 23:16 UTC GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0001250853-19-000101 · primary_doc.xml · derivative · entry 1

Beckett Darren · CIK 0001745828 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2024-10-10

Read SEC document
August 09, 2019 Filed Aug 16, 2019 15:11 UTC
Schwartz Carl I.Director · Chief Executive Officer
PurchaseCommon Stock 62,433 $0.75 $46,824.75
Disclosure

SEC source: 0001179110-19-009568 · edgar.xml · nonDerivative · entry 4

Schwartz Carl I. · CIK 0001573354 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000,000

Read SEC document
August 09, 2019 Filed Aug 22, 2019 16:07 UTC Amendment PurchaseCommon Stock 62,433 $0.75 $46,824.75
Disclosure

SEC source: 0001179110-19-009767 · edgar.xml · nonDerivative · entry 4

Schwartz Carl I. · CIK 0001573354 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000,000

Read SEC document
August 08, 2019 Filed Aug 16, 2019 15:11 UTC
Schwartz Carl I.Director · Chief Executive Officer
PurchaseCommon Stock 437,567 $0.69 $301,921.23
Disclosure

SEC source: 0001179110-19-009568 · edgar.xml · nonDerivative · entry 3

Schwartz Carl I. · CIK 0001573354 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,937,567

Read SEC document
August 08, 2019 Filed Aug 22, 2019 16:07 UTC Amendment PurchaseCommon Stock 437,567 $0.69 $301,921.23
Disclosure

SEC source: 0001179110-19-009767 · edgar.xml · nonDerivative · entry 3

Schwartz Carl I. · CIK 0001573354 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,937,567

Read SEC document
August 01, 2019 Filed Aug 9, 2019 21:49 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,922 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001250853-19-000096 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,922

Underlying: Common Stock · 22,922 shares

Expires 2024-07-31

Read SEC document
July 18, 2019 Filed Jul 23, 2019 01:10 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $1.24 $0.00
Disclosure

SEC source: 0001250853-19-000092 · primary_doc.xml · derivative · entry 1

Beckett Darren · CIK 0001745828 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2024-07-17

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in four annual installments of 1,250 shares each over four years from the date of grant; provided, in each case, that the Reporting Person remains an employee of the Issuer through such vesting date.

Read SEC document
July 18, 2019 Filed Jul 23, 2019 00:51 UTC
Orzechowski FrankCFO, PFO and PAO
GrantStock Option (right to buy) · Derivative 60,000 $0.00 Strike: $1.40 $0.00
Disclosure

SEC source: 0001250853-19-000091 · primary_doc.xml · derivative · entry 2

Orzechowski Frank · CIK 0001781860 · CFO, PFO and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2024-06-30

F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019.

F2 · derivative.exercise_date: The stock option vests as follows: 3,872 shares will vest and become exercisable on July 1, 2020; 9,000 shares will vest and become exercisable on July 1, 2021; 14,128 shares will vest and become exercisable on July 1, 2022, and 33,000 shares will vest and become exercisable on July 1, 2023, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

Read SEC document
July 18, 2019 Filed Jul 23, 2019 00:51 UTC
Orzechowski FrankCFO, PFO and PAO
GrantStock Option (right to buy) · Derivative 2,500 $0.00 Strike: $1.40 $0.00
Disclosure

SEC source: 0001250853-19-000091 · primary_doc.xml · derivative · entry 1

Orzechowski Frank · CIK 0001781860 · CFO, PFO and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019.

Read SEC document
July 18, 2019 Filed Jul 23, 2019 00:12 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,916 $0.00 Strike: $1.40 $0.00
Disclosure

SEC source: 0001250853-19-000090 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,916

Underlying: Common Stock · 22,916 shares

Expires 2024-06-30

F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019.

Read SEC document
June 01, 2019 Filed Jun 5, 2019 21:38 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,916 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001250853-19-000072 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,916

Underlying: Common Stock · 22,916 shares

Expires 2024-05-31

Read SEC document
May 07, 2019 Filed May 23, 2019 21:25 UTC PurchaseWarrants to purchase Common Stock · Derivative 200,000 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0001179110-19-006589 · edgar.xml · derivative · entry 3

Schwartz Carl I. · CIK 0001573354 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Carl I. Schwartz Revocable Family Trust dtd 03/14/19

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2024-11-08

F1 · price: Purchase price included 200,000 Warrants reported on table II.

F2 · derivative.exercise_date: Warrant contains a Beneficial Ownership Limitation provision that does not permit an exercise if it would result in the holder owning more than 4.99% of the outstanding shares of the Issuer. These limits may be increased up to 9.99% upon notice to the Issuer.

Read SEC document
May 07, 2019 Filed May 23, 2019 21:25 UTC PurchaseCommon Stock 400,000 $1.40 $560,000.00
Disclosure

SEC source: 0001179110-19-006589 · edgar.xml · nonDerivative · entry 2

Schwartz Carl I. · CIK 0001573354 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Carl I. Schwartz Revocable Family Trust dtd 3/14/19

Disclosed balance after: 400,000

F1 · price: Purchase price included 200,000 Warrants reported on table II.

Read SEC document
May 07, 2019 Filed May 24, 2019 15:46 UTC Amendment PurchaseWarrants to purchase Common Stock · Derivative 200,000 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0001179110-19-006622 · edgar.xml · derivative · entry 3

Schwartz Carl I. · CIK 0001573354 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Carl and Shirley Schwartz Trust dtd 3/14/19

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2024-11-08

F1 · price: Purchase price included 200,000 Warrants reported on table II.

F2 · derivative.exercise_date: Warrant contains a Beneficial Ownership Limitation provision that does not permit an exercise if it would result in the holder owning more than 4.99% of the outstanding shares of the Issuer. These limits may be increased up to 9.99% upon notice to the Issuer.

Read SEC document
May 07, 2019 Filed May 24, 2019 15:46 UTC Amendment PurchaseCommon Stock 400,000 $1.40 $560,000.00
Disclosure

SEC source: 0001179110-19-006622 · edgar.xml · nonDerivative · entry 2

Schwartz Carl I. · CIK 0001573354 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Carl and Shirley Schwartz Trust dtd 3/14/19

Disclosed balance after: 400,000

F1 · price: Purchase price included 200,000 Warrants reported on table II.

Read SEC document
May 01, 2019 Filed May 2, 2019 22:06 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,916 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001250853-19-000066 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,916

Underlying: Common Stock · 22,916 shares

Expires 2024-04-30

Read SEC document
April 01, 2019 Filed Apr 2, 2019 23:54 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,916 $0.00 Strike: $1.47 $0.00
Disclosure

SEC source: 0001250853-19-000062 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,916

Underlying: Common Stock · 22,916 shares

Expires 2024-03-29

Read SEC document
March 07, 2019 Filed Mar 29, 2019 22:32 UTC
Fisher Ronald Kenneth JrVP of Business Development
GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0001250853-19-000058 · primary_doc.xml · nonDerivative · entry 2

Fisher Ronald Kenneth Jr · CIK 0001698203 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

F2 · shares: The shares shown represent a stock award based on an applicable milestone being achieved.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 02:15 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,916 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001250853-19-000047 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,916

Underlying: Common Stock · 22,916 shares

Expires 2024-02-29

Read SEC document
February 01, 2019 Filed Feb 4, 2019 23:02 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,916 $0.00 Strike: $1.93 $0.00
Disclosure

SEC source: 0001250853-19-000037 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,916

Underlying: Common Stock · 22,916 shares

Expires 2024-01-31

Read SEC document
January 10, 2019 Filed Jan 14, 2019 21:18 UTC
Fisher Ronald Kenneth JrVP of Business Development
GrantStock Option (right to buy) · Derivative 11,832 $0.00 Strike: $2.02 $0.00
Disclosure

SEC source: 0001250853-19-000030 · primary_doc.xml · derivative · entry 1

Fisher Ronald Kenneth Jr · CIK 0001698203 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,832

Underlying: Common Stock · 11,832 shares

Expires 2024-01-09

Read SEC document
January 01, 2019 Filed Jan 4, 2019 02:28 UTC GrantStock Option (right to buy) · Derivative 3,750 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001250853-19-000007 · primary_doc.xml · derivative · entry 1

Beckett Darren · CIK 0001745828 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2023-12-31

F1 · derivative.exercise_date: (1) The stock option vests and becomes exercisable in four annual installments over four years from the date of grant, as follows: 937 shares will vest and become exercisable on December 31, 2019; 937 shares will vest and become exercisable on December 31, 2020; 938 shares will vest and become exercisable on December 31, 2021; and 938 shares will vest and become exercisable on December 31, 2022; provided, in each case, that the Reporting Person remains an employee of the Issuer through such vesting date.

Read SEC document
January 01, 2019 Filed Jan 4, 2019 01:53 UTC
Toups NannetteCFO, PFO and PAO
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001250853-19-000006 · primary_doc.xml · derivative · entry 1

Toups Nannette · CIK 0001718563 · CFO, PFO and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2023-12-31

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in four equal annual installments of 12,500 shares each over four years from the date of grant, beginning on December 31, 2019, provided, in each case, that the Reporting Person remains an employee of the Issuer through such vesting date.

Read SEC document
January 01, 2019 Filed Jan 4, 2019 01:27 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,916 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001250853-19-000005 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,916

Underlying: Common Stock · 22,916 shares

Expires 2023-12-31

Read SEC document
January 01, 2019 Filed Jan 4, 2019 01:11 UTC GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001250853-19-000004 · primary_doc.xml · nonDerivative · entry 1

Summers Kent J · CIK 0001728948 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Read SEC document
January 01, 2019 Filed Jan 4, 2019 00:53 UTC GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001250853-19-000003 · primary_doc.xml · nonDerivative · entry 1

Garofalo Frank J · CIK 0001698160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Read SEC document
January 01, 2019 Filed Jan 4, 2019 00:24 UTC GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001250853-19-000002 · primary_doc.xml · nonDerivative · entry 1

Battinelli Salvatore F · CIK 0001714848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,213

Read SEC document
January 01, 2019 Filed Jan 4, 2019 00:03 UTC GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001250853-19-000001 · primary_doc.xml · nonDerivative · entry 1

Duitch Dennis · CIK 0001352880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,489

Read SEC document
December 01, 2018 Filed Dec 5, 2018 01:12 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 22,916 $0.00 Strike: $1.51 $0.00
Disclosure

SEC source: 0001250853-18-000146 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,916

Underlying: Common Stock · 22,916 shares

Expires 2023-12-01

Read SEC document
November 01, 2018 Filed Nov 5, 2018 22:21 UTC
Rice John ReynoldsDirector · President and CEO
GrantStock Option (right to buy) · Derivative 68,750 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001250853-18-000138 · primary_doc.xml · derivative · entry 1

Rice John Reynolds · CIK 0001698204 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,750

Underlying: Common Stock · 68,750 shares

Expires 2023-11-01

Read SEC document
October 18, 2018 Filed Oct 23, 2018 00:16 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.21 $0.00
Disclosure

SEC source: 0001250853-18-000133 · primary_doc.xml · derivative · entry 1

Beckett Darren · CIK 0001745828 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2023-10-17

F1 · derivative.exercise_date: The stock option vests as follows: 1,000 shares will vest and become exercisable on Sepetember 16, 2019; 3,000 shares will vest and become exercisable on September 16, 2020; 5,000 shares will vest and become exercisable on September 16, 2021, and 11,000 shares will vest and become exercisable on September 16, 2022, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.